BACKGROUND: Burkholderia pseudomallei is a Category B select agent and the cause of melioidosis. Research funding for vaccine development has largely considered protection within the biothreat context, but the resulting vaccines could be applicable to populations who are at risk of naturally acquired melioidosis. Here, we discuss target populations for vaccination, consider the cost-benefit of different vaccination strategies and review potential vaccine candidates. METHODS AND FINDINGS: Meli...Expand abstract
- Publication status:
- Publisher copy:
- Copyright date:
Melioidosis vaccines: a systematic review and appraisal of the potential to exploit biodefense vaccines for public health purposes.
Views and Downloads
If you are the owner of this record, you can report an update to it here: Report update to this record